Cytokinetics (CYTK) Cash from Investing Activities Growth (1y) (2011 - 2026)
Cytokinetics (CYTK) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 90.55% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.53% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7,936.68% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 26.37% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -157.08% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -89.24% |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | -1,058.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,058.75% |
| Mar 31, 2026 | 37.31% |
| Dec 31, 2025 | -164.22% |
| Sep 30, 2025 | -57.55% |
| Jun 30, 2025 | 108.12% |
| Mar 31, 2025 | 224.61% |
| Dec 31, 2024 | 236.18% |
| Sep 30, 2024 | -161.68% |
| Jun 30, 2024 | -893.33% |
| Mar 31, 2024 | -80.28% |
| Dec 31, 2023 | -378.34% |
| Sep 30, 2023 | 124.98% |
| Jun 30, 2023 | 25.83% |
| Mar 31, 2023 | 357.47% |
| Dec 31, 2022 | -38.21% |
| Sep 30, 2022 | -40.08% |
| Jun 30, 2022 | 245.68% |
| Mar 31, 2022 | -1,118.33% |
| Dec 31, 2021 | 127.26% |
| Sep 30, 2021 | -106.60% |